The U.S. Department of Health and Human Services on Thursday unveiled a series of regulatory actions designed to effectively ban gender-affirming care for minors, building on broader Trump administration restrictions on transgender Americans.
The sweeping proposals — the most significant moves this administration has taken so far to restrict the use of puberty blockers, hormone therapy and surgical interventions for transgender children — include cutting off federal Medicaid and Medicare funding from hospitals that provide gender-affirming care to children and prohibiting federal Medicaid funding from being used on such procedures.
President Donald Trump signed an executive order that could reclassify marijuana as a less dangerous drug. The move could ease regulations and expand medical research by shifting marijuana from a Schedule I drug, like heroin, to a Schedule III substance, similar to ketamine.
The change won't legalize recreational use nationwide but may alter regulation and taxation. President Joe Biden's Justice Department had also proposed reclassifying marijuana, but Trump's order on Thursday could speed up the process.
Here's the latest:
Kennedy family member disagrees with name change to Trump-Kennedy Center
''President Trump and his administration have spent the past year repressing free expression, targeting artists, journalists, and comedians, and erasing the history of Americans whose contributions made our nation better and more just,'' Kerry Kennedy, president of Robert & Ethel Kennedy Human Rights Center, said in a statement.
Kennedy, whose brother Robert Kennedy Jr. is part of the Trump administration, added, ''President Kennedy proudly stood for justice, peace, equality, dignity, diversity, and compassion for those who suffer. President Trump stands in opposition to these values, and his name should not be placed alongside President Kennedy's.''